International Biotechnology Trust

Transforming healthcare

Managing a London Stock Exchange listed Biotechnology Investment Trust

SV Health Managers LLP is fund manager of the London-based International Biotechnology Trust plc. This Investment Trust is publicly listed on the London Stock Exchange under the ticker IBT LN. 85-90% of the trust is invested in a portfolio of stocks publicly quoted on the world’s major stock exchanges, with the remainder invested in unquoted companies through SV Life Sciences Fund VI and a few direct unquoted investments. The portfolio is focused on companies aiming to develop breakthrough treatments for conditions that affect millions, including cancer, rare diseases, infectious diseases, and cardiovascular disease. As well as aiming to provide investors with a capital return, the trust also pays a dividend from capital reserves of 4% of NAV per annum.

To learn more about International Biotechnology Trust plc, visit www.ibtplc.com